These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7976630)

  • 1. Treatment of vasogenic brain edema with arginine vasopressin receptor antagonist--an experimental study.
    Nagao S; Kagawa M; Bemana I; Kuniyoshi T; Ogawa T; Honma Y; Kuyama H
    Acta Neurochir Suppl (Wien); 1994; 60():502-4. PubMed ID: 7976630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
    Kagawa M; Nagao S; Bemana I
    J Neurotrauma; 1996 May; 13(5):273-9. PubMed ID: 8797177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.
    Bemana I; Nagao S
    Neurosurgery; 1999 Jan; 44(1):148-54; discussion 154-5. PubMed ID: 9894975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OPC-21268, an orally effective, nonpeptide arginine vasopressin V1 receptor antagonist reduces vasogenic brain edema.
    Bemana I; Takahashi E; Nakamura T; Kuyama H; Nagao S
    Acta Neurochir Suppl; 1997; 70():194-7. PubMed ID: 9416320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of arginine vasopressin receptor antagonist on the rat cold-injured brain].
    Kagawa M; Nagao S
    No Shinkei Geka; 1993 Dec; 21(12):1103-7. PubMed ID: 8259220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats.
    Rosenberg GA; Scremin O; Estrada E; Kyner WT
    Stroke; 1992 Dec; 23(12):1767-73; discussion 1773-4. PubMed ID: 1448828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with nicardipine, phenobarbital, and methylprednisolone ameliorates vasogenic brain edema.
    Lin SZ; Chiou TL; Chiang YH; Song WS
    Acta Neurochir Suppl (Wien); 1994; 60():528-30. PubMed ID: 7976639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of traumatic brain edema by multiple doses of mannitol.
    von Berenberg P; Unterberg A; Schneider GH; Lanksch WR
    Acta Neurochir Suppl (Wien); 1994; 60():531-3. PubMed ID: 7976640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdural cortical stabbing facilitates the drainage of edema fluid out of cold-injured brain.
    Chiou TL; Chiang YH; Song WS; Lin SS
    Acta Neurochir Suppl (Wien); 1994; 60():459-61. PubMed ID: 7976620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannitol, intracranial pressure, and vasogenic edema.
    Hartwell RC; Sutton LN
    Neurosurgery; 1993 Mar; 32(3):444-50; discussion 450. PubMed ID: 8455770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
    Zeynalov E; Jones SM; Seo JW; Snell LD; Elliott JP
    PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide (ANP) attenuates brain oedema accompanying experimental subarachnoid haemorrhage.
    Dóczi TP; Joó F; Balás I
    Acta Neurochir (Wien); 1995; 132(1-3):87-91. PubMed ID: 7754864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute isotonic saline administration on serum osmolality, serum electrolytes, brain water content and intracranial pressure.
    James HE; Schneider S
    Acta Neurochir Suppl (Wien); 1993; 57():89-93. PubMed ID: 8421958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of vasopressin v1a receptors after traumatic brain injury.
    Szmydynger-Chodobska J; Chung I; Koźniewska E; Tran B; Harrington FJ; Duncan JA; Chodobski A
    J Neurotrauma; 2004 Aug; 21(8):1090-102. PubMed ID: 15319008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.
    Liu X; Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
    Neurocrit Care; 2010 Feb; 12(1):124-31. PubMed ID: 19806476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
    Kleindienst A; Dunbar JG; Glisson R; Marmarou A
    Acta Neurochir (Wien); 2013 Jan; 155(1):151-64. PubMed ID: 23188468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats.
    Schulz J; Plesnila N; Eriskat J; Stoffel M; Pruneau D; Baethmann A
    Acta Neurochir Suppl; 2000; 76():137-9. PubMed ID: 11449993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihistaminics on experimental brain edema.
    Schilling L; Wahl M
    Acta Neurochir Suppl (Wien); 1994; 60():79-82. PubMed ID: 7976662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 21-Aminosteroid U-74389F reduces vasogenic brain edema.
    Schneider GH; Unterberg A; Lanksch WR
    Acta Neurochir Suppl (Wien); 1994; 60():516-8. PubMed ID: 7976635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
    Vakili A; Kataoka H; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.